Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Mosunetuzumab With Polatuzumab Vedotin: Subgroup Analyses... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Mosunetuzumab With Polatuzumab Vedotin: Subgroup Analyses in Patients (pts) With Primary Refractory or Early Relapsed Large B-Cell Lymphoma (LBCL)
0
Authors
Sarit Assouline
18 more
Sarit Assouline
•
Lihua Budde
16 more
•
Manali Kamdar
Published
September 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Clinical Lymphoma Myeloma & Leukemia
Topics
Physics
Cancer Oncology
Medicine
Dermatology
Internal Medicine
Show all topics
DOI
10.1016/s2152-2650(24)00790-0
